New interaction discovered between vitamin D and certain protein in tuberculosis Vitamin D Council describes the study
- “When vitamin D levels were low, IL-32 was not able to kill the bacteria,”
- . . applied for a patent application for further development of IL-32 as a potential diagnostic marker to see which patients with latent TB are at risk for activation of the disease, as well as for use as a possible therapeutic to treat tuberculosis by stimulating antimicrobial activity.